Description

Diclazuril CAS NO 101831-37-2 is a synthetic triazine-based coccidiostat, a vital active pharmaceutical ingredient (API) in veterinary medicine. Its primary value lies in its potent and specific activity against apicomplexan parasites, offering a critical tool for maintaining animal health and productivity. This compound is essential for manufacturers in the animal health industry, particularly for producing premixes, medicated feeds, and pharmaceutical formulations for poultry, swine, and other livestock.

Application

• Veterinary Anticoccidial Agent: Primary use in the prevention and treatment of coccidiosis in poultry (broilers, layers, turkeys) and other livestock.
• Medicated Feed Additive: Incorporated into premixes and complete feeds to provide continuous, prophylactic protection against parasitic infections.
• Veterinary Pharmaceutical Formulations: Used as the active ingredient in oral suspensions, soluble powders, and other dosage forms for therapeutic intervention.
• Swine Health Management: Employed for the control of Isospora suis infections in piglets, reducing pre-weaning diarrhea and mortality.
• Companion Animal Medicine: Investigational and applied use for treating specific protozoal infections (e.g., toxoplasmosis) in dogs and cats.
• Aquaculture: Potential application for controlling related parasitic diseases in farmed fish species.
• Research & Development: Serves as a reference standard and key intermediate in the development of new antiparasitic agents.

Basic Information

Product Name	Diclazuril
CAS No.	101831-37-2
Molecular Formula	C17H9Cl3N4O2
Molecular Weight	407.63 g/mol
Synonyms	4-Chlorophenyl [2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile; Diclazuril [USAN:INN:BAN]; Clinacox; Vecoxan; 2,6-Dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; Letek; Diclazurilum
EINECS	Contact for details

Quality Control

Our Diclazuril is manufactured under strict quality management systems to ensure batch-to-batch consistency and reliability. The product undergoes comprehensive analytical testing, including HPLC for assay and impurity profiling, residual solvent analysis, and identification by IR and MS. A Certificate of Analysis (COA) detailing all specifications is provided with each shipment. We support compliance with relevant veterinary pharmacopoeia standards and can tailor specifications to meet specific customer requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Related Substances (HPLC)	Individual impurity: ≤ 0.5% Total impurities: ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.